Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLLS Cellectis S.A.

休市中 09-11 16:00:00 EDT

3.10

-0.02

-0.64%

盘后3.10

+0.000.00%

19:30 EDT

最高3.18	最低3.01	成交量7.56万
今开3.11	昨收3.12	日振幅5.45%
总市值3.13亿	流通市值2.32亿	总股本1.01亿
成交额23.43万	换手率0.10%	流通股本7,470万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLLS","market":"US","secType":"STK","nameCN":"Cellectis S.A.","latestPrice":3.1,"timestamp":1789156800000,"preClose":3.12,"halted":0,"volume":75583,"hourTrading":{"tag":"盘后","latestPrice":3.1,"preClose":3.1,"latestTime":"19:30 EDT","volume":869,"amount":2693.9,"timestamp":1789169406231,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006410256410256416,"floatShares":74700400,"shares":101000000,"eps":-0.647888,"marketStatus":"休市中","change":-0.02,"latestTime":"09-11 16:00:00 EDT","open":3.105,"high":3.18,"low":3.01,"amount":234324.1928005,"amplitude":0.054487,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.647888,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":1,"adrRate":1,"listingDate":1427256000000,"exchange":"NASDAQ","adjPreClose":3.12,"postHourTrading":{"tag":"盘后","latestPrice":3.1,"preClose":3.1,"latestTime":"19:30 EDT","volume":869,"amount":2693.9,"timestamp":1789169406231,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.2970258821709595,"impliedVol":0.0007,"impliedVolPercentile":0.0637},"requestUrl":"/m/hq/s/CLLS","defaultTab":"news","newsList":[{"id":"2516634916","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨6.31%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516634916?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012356,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速上涨6.31%。截至发稿，该股报1.37美元/股，成交量6275股，换手率0.01%，振幅0.02%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.44%、27.60%、23.01%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Cibus, Inc.，振幅分别为21.22%、19.25%、9.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223236abe63383&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223236abe63383&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516031173","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 快速跳水5.26%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516031173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516031173?lang=zh_cn&edition=full","pubTime":"2025-03-01 03:13","pubTimestamp":1740769991,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日03时13分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速下跌5.26%。截至发稿，该股报1.26美元/股，成交量11.4681万股，换手率0.11%，振幅4.51%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301031311abe12976&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301031311abe12976&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514043332","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514043332?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:24","pubTimestamp":1740687840,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时24分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速跳水5.00%。截至发稿，该股报1.33美元/股，成交量20.9548万股，换手率0.21%，振幅5.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022804240098955083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022804240098955083&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514101306","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌5.87%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514101306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514101306?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:21","pubTimestamp":1740496901,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时21分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅下挫5.87%。截至发稿，该股报1.41美元/股，成交量2.9474万股，换手率0.03%，振幅7.34%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.80%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523214198925807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523214198925807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511961106","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 大幅拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511961106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511961106?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:31","pubTimestamp":1739543482,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速上涨5.24%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.18%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223122a24600b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223122a24600b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRPX","BK4007","CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511173525","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大涨5.08%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511173525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511173525?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:30","pubTimestamp":1739457049,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时30分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅上涨5.08%。截至发稿，该股报1.55美元/股，成交量784股，换手率0.00%，振幅0.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.00%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223049abcdb1c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223049abcdb1c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510863474","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 急速拉升5.23%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510863474?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:33","pubTimestamp":1739197999,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时33分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速拉升5.23%。截至发稿，该股报1.61美元/股，成交量1856股，换手率0.00%，振幅2.61%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.32%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223319a240a274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223319a240a274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509277199","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509277199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509277199?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:53","pubTimestamp":1738853580,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时53分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速上涨5.62%。截至发稿，该股报1.69美元/股，成交量641股，换手率0.00%，振幅2.06%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.36%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225300961a1cac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206225300961a1cac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509461259","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨5.13%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509461259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509461259?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:50","pubTimestamp":1738687853,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时50分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速拉升5.13%。截至发稿，该股报1.64美元/股，成交量1.9512万股，换手率0.02%，振幅2.56%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为1.35%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205005053abc24298&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205005053abc24298&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149514","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149514?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:37","pubTimestamp":1738593467,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时37分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价大幅下挫5.59%。截至发稿，该股报1.52美元/股，成交量7820股，换手率0.01%，振幅1.50%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.40%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322374798797033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322374798797033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506511035","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 大幅拉升7.14%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506511035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506511035?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074684,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速上涨7.14%。截至发稿，该股报1.65美元/股，成交量3158股，换手率0.00%，振幅0.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.01%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822312498756b5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822312498756b5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506307574","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506307574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506307574?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:50","pubTimestamp":1737996616,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时50分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价大幅下挫5.39%。截至发稿，该股报1.58美元/股，成交量3.0765万股，换手率0.03%，振幅2.99%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为1.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128005016a2318766&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128005016a2318766&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505613168","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨6.41%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505613168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505613168?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:56","pubTimestamp":1737730610,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时56分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价快速拉升6.41%。截至发稿，该股报1.66美元/股，成交量5.4055万股，换手率0.05%，振幅8.33%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124225650a22e5ff0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124225650a22e5ff0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505962047","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505962047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505962047?lang=zh_cn&edition=full","pubTime":"2025-01-24 02:49","pubTimestamp":1737658184,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日02时49分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价急速拉升5.23%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为1.13%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124024944abb62d46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124024944abb62d46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505271849","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大涨5.74%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505271849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505271849?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:34","pubTimestamp":1737470085,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时34分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价大幅上涨5.74%。截至发稿，该股报1.57美元/股，成交量8649股，换手率0.01%，振幅107.43%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.88%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223445960bb9ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223445960bb9ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504945853","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 快速下跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504945853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504945853?lang=zh_cn&edition=full","pubTime":"2025-01-17 01:57","pubTimestamp":1737050220,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日01时57分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价急速下挫5.85%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.20%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117015700abad7c39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117015700abad7c39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503628466","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 急速上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503628466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503628466?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951491,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价快速上涨5.36%。截至发稿，该股报1.77美元/股，成交量5244股，换手率0.01%，振幅0.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.68%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152231329604b3c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152231329604b3c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503273571","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘大幅拉升6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503273571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503273571?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:47","pubTimestamp":1736866064,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时47分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价快速拉升6.55%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.45%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501142247449603831b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501142247449603831b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503580363","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 临近午盘股价大跌5.41%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503580363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503580363?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:40","pubTimestamp":1736786401,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时40分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价大幅下挫5.41%。截至发稿，该股报1.75美元/股，成交量9.224万股，换手率0.09%，振幅6.95%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140040019864eb96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140040019864eb96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KAPA","CLLS","KAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501775554","title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501775554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501775554?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:54","pubTimestamp":1736348049,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时54分，Cellectis Ads Each Repr 1 Ord Spon股票出现波动，股价快速下挫5.22%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体涨幅为0.05%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，拥有异体嵌合抗原受体 T 细胞，是免疫肿瘤学领域的候选产品，和基因编辑的造血干细胞和祖细胞，是其他治疗适应症的候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225409985f7d35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225409985f7d35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectis.com","stockEarnings":[{"period":"1week","weight":-0.0432},{"period":"1month","weight":0.0544},{"period":"3month","weight":0.0032},{"period":"6month","weight":-0.0936},{"period":"1year","weight":0.0403},{"period":"ytd","weight":-0.3595}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cellectis S.A.于2000年1月4日成立。该公司是一家处于临床阶段的生物技术公司，利用他们的核心专有技术开发基于基因编辑的产品，拥有一系列同种异体嵌合抗原受体T细胞，即免疫肿瘤学领域的候选产品和基因编辑造血干细胞和祖细胞，即HSPC，其他治疗适应症的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.025762},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.069977},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.047671},{"month":4,"riseRate":0.416667,"avgChangeRate":0.04499},{"month":5,"riseRate":0.583333,"avgChangeRate":0.041237},{"month":6,"riseRate":0.25,"avgChangeRate":-0.081754},{"month":7,"riseRate":0.333333,"avgChangeRate":0.030598},{"month":8,"riseRate":0.75,"avgChangeRate":0.06991},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.105827},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.048106},{"month":11,"riseRate":0.545455,"avgChangeRate":0.268959},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.008306}],"exchange":"NASDAQ","name":"Cellectis S.A.","nameEN":"Cellectis SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cellectis S.A.(CLLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cellectis S.A.,CLLS,Cellectis S.A.股票,Cellectis S.A.股票老虎,Cellectis S.A.股票老虎国际,Cellectis S.A.行情,Cellectis S.A.股票行情,Cellectis S.A.股价,Cellectis S.A.股市,Cellectis S.A.股票价格,Cellectis S.A.股票交易,Cellectis S.A.股票购买,Cellectis S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectis S.A.(CLLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cellectis S.A.(CLLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}